Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

11 results about "Nitric oxide" patented technology

Nitric oxide (nitrogen oxide or nitrogen monoxide) is a colorless gas with the formula NO. It is one of the principal oxides of nitrogen. Nitric oxide is a free radical, i.e., it has an unpaired electron, which is sometimes denoted by a dot in its chemical formula, i.e., ·NO. Nitric oxide is also a heteronuclear diatomic molecule, a historic class that drew researches which spawned early modern theories of chemical bonding.

Compositions for sustrained release of nitric oxide, methods of preparing same and uses thereof

ActiveUS20090297634A1BiocideOrganic active ingredientsNitric oxideChemistry
The invention provides compositions for releasing nitric oxide (NO) comprising a matrix that encapsulates nitric oxide. Nitric oxide is released when the composition is exposed to an aqueous environment. The invention further provides methods of preparing the compositions and uses of the compositions for treating infections and disorders.
Owner:ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIV

Method and device to prevent ventilator acquired pneumonia using nitric oxide

InactiveUS20080167603A1Risk minimizationPrevent ventilator acquired pneumoniaRespiratorsInorganic active ingredientsNitric oxideSecretion
A respiratory assist device and method for the prevention of ventilator acquired pneumonia in a patient is described. The respiratory assist device administers nitric oxide to the oropharyngeal area in order to decontaminate or prevent the contamination of secretions that collect in the oropharyngeal area during intubation of the patient. The respiratory assist device and method may be adapted for use, for example, as an endotracheal tube or as a tracheotomy tube.
Owner:STENZLER ALEX +1

USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE

InactiveUS20100324107A1Improve the quality of lifeBiocideOrganic chemistryPhthalocyanine derivativesNitric oxide
The present invention refers to the use of phthalimide and/or sulphonamide derivatives with nitric oxide donor properties, which have important activities in increasing the gamma-globin gene expression and anti-inflammatory and analgesic activities, effective in the treatment of hematologic diseases which require reducing the TNF-α levels and an exogenous source of nitric oxide. More particularly, the present invention describes the use of such phthalimide and/or sulphonamide derivatives for the treatment of sickle-cell disease. The invention also has as a novel characteristic the disclosure of new functionalized phthalimide derivatives designed from the prototypes thalidomide and hydroxyurea, and designed rationally through the strategy of molecular hybridization for the treatment of said diseases. The invention still discloses a new method for obtaining a specific sulphonamide derivative which can be used in the preparation of a drug for the treatment of diseases which require reducing the levels of the TNF-α factor and an exogenous source of nitric oxide.
Owner:UNIV ESTADUAL DE CAMPINAS UNICAMP +2

High-voltage electro-catalysis discharge reactor

ActiveCN106475029ALow operating costImprove efficiencyDispersed particle separationEnergy based chemical/physical/physico-chemical processesNitric oxideHigh voltage
The invention discloses a high-voltage electro-catalysis discharge reactor which comprises a positive polar discharge reactor and a negative polar discharge reactor which are connected through a gas pipeline, wherein the positive polar discharge reactor comprises at least one discharge structure unit I; each discharge structure unit I comprises at least one group of discharge assemblies I; each discharge assembly I comprises a PCB I uniformly equipped with discharge needles, two discharge reactors I fitted to two sides of the PCB I and two module insulation plates I fitted to the outer sides of the discharge reactors I; and catalytic agent carriers are further embedded into the discharge reactors I. The high-voltage electro-catalysis discharge reactor can efficiently decompose oxysulphide, nitric oxide and carbon dioxide under the reducing atmosphere and can remove various heavy metal pollutions and volatile organic compounds under the oxidizing atmosphere.
Owner:QIDONG HUIHUA HEALTH TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products